The South American pharmaceutical ingredients market is evolving from quiet dependency into a bold narrative of re-invention. For decades, the region relied heavily on imported Active Pharmaceutical Ingredients (APIs) and intermediates, but new economic realities, global supply disruptions, and health crises have shifted the focus inward.